1,3-bis(tris(hydroxymethyl)methylamino)propane has been researched along with 1-carboxyglutamic acid in 1 studies
| Studies (1,3-bis(tris(hydroxymethyl)methylamino)propane) | Trials (1,3-bis(tris(hydroxymethyl)methylamino)propane) | Recent Studies (post-2010) (1,3-bis(tris(hydroxymethyl)methylamino)propane) | Studies (1-carboxyglutamic acid) | Trials (1-carboxyglutamic acid) | Recent Studies (post-2010) (1-carboxyglutamic acid) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 653 | 8 | 41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrouz, H; Mahboudi, F; Maleknia, S; Marjaninia, S; Molavi, B; Tahmasbi, H; Zarezadeh, N | 1 |
1 other study(ies) available for 1,3-bis(tris(hydroxymethyl)methylamino)propane and 1-carboxyglutamic acid
| Article | Year |
|---|---|
Elimination of ghost peaks by optimization of anion exchange chromatography method for determination of gamma-carboxyglutamic acid (Gla)-domainless impurity in recombinant activated clotting factor VII drug products.
Topics: 1-Carboxyglutamic Acid; Buffers; Chemistry, Pharmaceutical; Chromatography, Ion Exchange; Drug Contamination; Factor VIIa; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tromethamine | 2019 |